Cargando…

Lymphadenectomy for primary ovarian cancer: a systematic review and meta-analysis

OBJECTIVE: To assess the effectiveness of lymphadenectomy at primary debulking surgery (PDS) on the survival of patients with epithelial ovarian cancer (EOC). METHODS: We searched PubMed, Ichushi, and the Cochrane Library. Randomized controlled trials (RCTs) and retrospective cohort studies comparin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiyoda, Tatsuyuki, Sakurai, Manabu, Satoh, Toyomi, Nagase, Satoru, Mikami, Mikio, Katabuchi, Hidetaka, Aoki, Daisuke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7440977/ https://www.ncbi.nlm.nih.gov/pubmed/32808497 http://dx.doi.org/10.3802/jgo.2020.31.e67

Ejemplares similares

The 2020 Japan Society of Gynecologic Oncology guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer
por: Tokunaga, Hideki, et al.
Publicado: (2021)

Role of lymphadenectomy for ovarian cancer
por: Mikami, Mikio
Publicado: (2014)

A retrospective study for investigating the relationship between old and new staging systems with prognosis in ovarian cancer using gynecologic cancer registry of Japan Society of Obstetrics and Gynecology (JSOG): disparity between serous carcinoma and clear cell carcinoma
por: Yamagami, Wataru, et al.
Publicado: (2020)

Opportunistic bilateral salpingectomy during benign gynecological surgery for ovarian cancer prevention: a survey of Gynecologic Oncology Committee of Japan Society of Obstetrics and Gynecology
por: Mikami, Mikio, et al.
Publicado: (2017)

Impact of lymphadenectomy on the treatment of endometrial cancer using data from the JSOG cancer registry
por: Saotome, Keiko, et al.
Publicado: (2021)

The trend and outcome of postsurgical therapy for high-risk early-stage cervical cancer with lymph node metastasis in Japan: a report from the Japan Society of Gynecologic Oncology (JSGO) guidelines evaluation committee
por: Ikeda, Masae, et al.
Publicado: (2021)

Effectiveness of adjuvant systemic chemotherapy for intermediate-risk stage IB cervical cancer
por: Matsuo, Koji, et al.
Publicado: (2017)

Current status of hereditary breast and ovarian cancer practice among gynecologic oncologists in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO)
por: Kobayashi, Yusuke, et al.
Publicado: (2022)

Japan Society of Gynecologic Oncology 2018 guidelines for treatment of uterine body neoplasms
por: Yamagami, Wataru, et al.
Publicado: (2019)

Association between hospital treatment volume and survival of women with gynecologic malignancy in Japan: a JSOG tumor registry-based data extraction study
por: Machida, Hiroko, et al.
Publicado: (2021)

Association of menopause, aging and treatment procedures with positive margins after therapeutic cervical conization for CIN 3: a retrospective study of 8,856 patients by the Japan Society of Obstetrics and Gynecology
por: Ikeda, Masae, et al.
Publicado: (2021)

Lymphadenectomy issues in endometrial cancer
por: Konno, Yosuke, et al.
Publicado: (2021)

Patient-derived ovarian cancer organoids capture the genomic profiles of primary tumours applicable for drug sensitivity and resistance testing
por: Nanki, Yoshiko, et al.
Publicado: (2020)

Impact of institutional accreditation by the Japan Society of Gynecologic Oncology on the treatment and survival of women with cervical cancer
por: Mikami, Mikio, et al.
Publicado: (2018)

Clinical statistics of gynecologic cancers in Japan
por: Yamagami, Wataru, et al.
Publicado: (2017)

Analysis of pathological and clinical characteristics of cervical conization according to age group in Japan
por: Murakami, Isao, et al.
Publicado: (2020)

Uterine cervical cancer associated with obstructed hemivagina and ipsilateral renal agenesis (OHVIRA) syndrome: A case report and review of the literature
por: Oka, Emiko, et al.
Publicado: (2020)

Assessing the effect of guideline introduction on clinical practice and outcome in patients with endometrial cancer in Japan: a project of the Japan Society of Gynecologic Oncology (JSGO) guideline evaluation committee
por: Shigeta, Shogo, et al.
Publicado: (2017)

The efficacy and safety profile of 2-weekly dosing of bevacizumab-containing chemotherapy for platinum-resistant recurrent ovarian cancer
por: Sekine, Masayuki, et al.
Publicado: (2021)

Correction to: The efficacy and safety profile of 2-weekly dosing of bevacizumab-containing chemotherapy for platinum-resistant recurrent ovarian cancer
por: Sekine, Masayuki, et al.
Publicado: (2021)

The use of conization to identify and treat severe lesions among prediagnosed CIN1 and 2 patients in Japan
por: Mikami, Mikio, et al.
Publicado: (2018)

Impact of Lymphadenectomy on Outcomes of Early-Stage Ovarian Cancer: A Systematic Review and Meta-Analysis
por: Yao, Guorong, et al.
Publicado: (2021)

Clinical significance of systematic retroperitoneal lymphadenectomy during interval debulking surgery in advanced ovarian cancer patients
por: Iwase, Haruko, et al.
Publicado: (2015)

Quality indicators for cervical cancer care in Japan
por: Watanabe, Tomone, et al.
Publicado: (2018)

Ovarian Cancer Stemness: Biological and Clinical Implications for Metastasis and Chemotherapy Resistance
por: Motohara, Takeshi, et al.
Publicado: (2019)

Prognostic Significance of Systematic Lymphadenectomy in Patients With Optimally Debulked Advanced Ovarian Cancer: A Meta-Analysis
por: Wang, Yizi, et al.
Publicado: (2020)

High Pretreatment Plasma D-dimer Levels Are Associated With Poor Prognosis in Patients With Ovarian Cancer Independently of Venous Thromboembolism and Tumor Extension
por: Sakurai, Manabu, et al.
Publicado: (2015)

Intraoperative Capsule Rupture, Postoperative Chemotherapy, and Survival of Women With Stage I Epithelial Ovarian Cancer
por: Matsuo, Koji, et al.
Publicado: (2019)

Impact of COVID-19 on gynecologic cancer treatment in Japan: a nationwide survey by the Japan Society of Gynecologic Oncology (JSGO)
por: Nogami, Yuya, et al.
Publicado: (2021)

Clinical implications of next‐generation sequencing‐based panel tests for malignant ovarian tumors
por: Saotome, Keiko, et al.
Publicado: (2020)

Application of lymphangiography in para-aortic lymphadenectomy for ovarian cancer
por: Xu, Zhen, et al.
Publicado: (2021)

Prognosis of lymphadenectomy in malignant ovarian germ cell tumor
por: Lv, Bin, et al.
Publicado: (2023)

The value of systematic lymphadenectomy during debulking surgery in the treatment of ovarian cancer: a meta-analysis of randomized controlled trials
por: Lin, Qingqing, et al.
Publicado: (2020)

Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis
por: Maggioni, A, et al.
Publicado: (2006)

Systematic lymphadenectomy in ovarian cancer at second-look surgery: a randomised clinical trial
por: Dell’ Anna, T, et al.
Publicado: (2012)

Posttreatment human papillomavirus testing for residual or recurrent high-grade cervical intraepithelial neoplasia: a pooled analysis
por: Onuki, Mamiko, et al.
Publicado: (2016)

Japan Society of Gynecologic Oncology guidelines 2015 for the treatment of vulvar cancer and vaginal cancer
por: Saito, Toshiaki, et al.
Publicado: (2017)

Differentiation of epithelial ovarian cancer subtypes by use of imaging and clinical data: a detailed analysis
por: Tanaka, Yumiko Oishi, et al.
Publicado: (2016)

Lymphadenectomy in ovarian cancers: a meta-analysis of hazard ratios from randomized clinical trials
por: Purwar, Roli, et al.
Publicado: (2022)

Role of systematic lymphadenectomy as part of primary debulking surgery for optimally cytoreduced advanced ovarian cancer: Reappraisal in the era of radical surgery
por: Eoh, Kyung Jin, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_klh30cohvnteco8kk1o9mije1t